日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Expression of neuroblastoma-related genes in bone marrow at end of high-risk neuroblastoma therapy

高危神经母细胞瘤治疗结束时骨髓中神经母细胞瘤相关基因的表达

Asgharzadeh, Shahab; Marachelian, Araz; Villablanca, Judith G; Liu, Wei Yao; Kennedy, Rebekah; Sposto, Richard; Naranjo, Arlene; Tenney, Sheena; Yu, Alice L; Ozkaynak, M Fevzi; Sondel, Paul M; Park, Julie R; Seeger, Robert C

Cross-Cohort Analysis Identifies a TEAD4-MYCN Positive Feedback Loop as the Core Regulatory Element of High-Risk Neuroblastoma

跨队列分析发现 TEAD4-MYCN 正反馈环路是高危神经母细胞瘤的核心调控元件

Rajbhandari, Presha; Lopez, Gonzalo; Capdevila, Claudia; Salvatori, Beatrice; Yu, Jiyang; Rodriguez-Barrueco, Ruth; Martinez, Daniel; Yarmarkovich, Mark; Weichert-Leahey, Nina; Abraham, Brian J; Alvarez, Mariano J; Iyer, Archana; Harenza, Jo Lynne; Oldridge, Derek; De Preter, Katleen; Koster, Jan; Asgharzadeh, Shahab; Seeger, Robert C; Wei, Jun S; Khan, Javed; Vandesompele, Jo; Mestdagh, Pieter; Versteeg, Rogier; Look, A Thomas; Young, Richard A; Iavarone, Antonio; Lasorella, Anna; Silva, Jose M; Maris, John M; Califano, Andrea

MYC-family protein overexpression and prominent nucleolar formation represent prognostic indicators and potential therapeutic targets for aggressive high-MKI neuroblastomas: a report from the children's oncology group

MYC家族蛋白过表达和显著的核仁形成是侵袭性高MKI神经母细胞瘤的预后指标和潜在治疗靶点:儿童肿瘤协作组的一份报告

Niemas-Teshiba, Risa; Matsuno, Ryosuke; Wang, Larry L; Tang, Xao X; Chiu, Bill; Zeki, Jasmine; Coburn, Jeannine; Ornell, Kimberly; Naranjo, Arlene; Van Ryn, Collin; London, Wendy B; Hogarty, Michael D; Gastier-Foster, Julie M; Look, A Thomas; Park, Julie R; Maris, John M; Cohn, Susan L; Seeger, Robert C; Asgharzadeh, Shahab; Ikegaki, Naohiko; Shimada, Hiroyuki

Biological roles and potential applications of immune cell-derived extracellular vesicles

免疫细胞来源的细胞外囊泡的生物学作用及潜在应用

Wen, Chuan; Seeger, Robert C; Fabbri, Muller; Wang, Larry; Wayne, Alan S; Jong, Ambrose Y

TGFβR1 Blockade with Galunisertib (LY2157299) Enhances Anti-Neuroblastoma Activity of the Anti-GD2 Antibody Dinutuximab (ch14.18) with Natural Killer Cells.

Galunisertib (LY2157299) 阻断 TGFβR1 可增强抗 GD2 抗体 Dinutuximab (ch14.18) 与自然杀伤细胞的抗神经母细胞瘤活性

Tran Hung C, Wan Zesheng, Sheard Michael A, Sun Jianping, Jackson Jeremy R, Malvar Jemily, Xu Yibing, Wang Larry, Sposto Richard, Kim Eugene S, Asgharzadeh Shahab, Seeger Robert C

More than the genes, the tumor microenvironment in neuroblastoma

神经母细胞瘤中,肿瘤微环境比基因更为重要。

Borriello, Lucia; Seeger, Robert C; Asgharzadeh, Shahab; DeClerck, Yves A

A novel minimal residual disease model of neuroblastoma in mice

小鼠神经母细胞瘤的新型微小残留病模型

Jackson, Jeremy R; Kim, Youngleem; Seeger, Robert C; Kim, Eugene S

A LIN28B-RAN-AURKA Signaling Network Promotes Neuroblastoma Tumorigenesis

LIN28B-RAN-AURKA信号网络促进神经母细胞瘤的发生

Schnepp, Robert W; Khurana, Priya; Attiyeh, Edward F; Raman, Pichai; Chodosh, Sara E; Oldridge, Derek A; Gagliardi, Maria E; Conkrite, Karina L; Asgharzadeh, Shahab; Seeger, Robert C; Madison, Blair B; Rustgi, Anil K; Maris, John M; Diskin, Sharon J

Age-dependent prognostic effect by Mitosis-Karyorrhexis Index in neuroblastoma: a report from the Children's Oncology Group

神经母细胞瘤中,有丝分裂-核碎裂指数的年龄依赖性预后效应:来自儿童肿瘤协作组的报告

Teshiba, Risa; Kawano, Shinya; Wang, Larry L; He, Lejian; Naranjo, Arlene; London, Wendy B; Seeger, Robert C; Gastier-Foster, Julie M; Look, A Thomas; Hogarty, Michael D; Cohn, Susan L; Maris, John M; Park, Julie R; Shimada, Hiroyuki

Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial

高危神经母细胞瘤患者接受经净化处理的外周血干细胞移植与未经净化处理的外周血干细胞移植的比较(COG A3973):一项随机3期试验

Kreissman, Susan G; Seeger, Robert C; Matthay, Katherine K; London, Wendy B; Sposto, Richard; Grupp, Stephan A; Haas-Kogan, Daphne A; Laquaglia, Michael P; Yu, Alice L; Diller, Lisa; Buxton, Allen; Park, Julie R; Cohn, Susan L; Maris, John M; Reynolds, C Patrick; Villablanca, Judith G